Brief: Immunotech Biopharm & China Resources Pharmaceutical Enter Strategic Cooperation Framework Deal
Sept 17 (Reuters) - China Resources Pharmaceutical Group Ltd
3320.HK :
* CO & CHINA RESOURCES PHARMACEUTICAL GROUP ENTERED INTO A
STRATEGIC COOPERATION FRAMEWORK AGREEMENT
* UNDER DEAL PARTIES AGREED TO COOPERATE IN SALES AND
DISTRIBUTION
OF EAL ® WITHIN PRC, AMONG OTHERS
Source text for Eikon: ID:nHKS2G6NtV
Further company coverage: 3320.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immunotech Biopharm
See all newsBrief: Immunotech Biopharm Gets Approval In Sept 2025 For Clinical Translational Application Of Atl In Hainan
Brief: Immunotech Biopharm Receives Notice Of Rejection For Conditional New Drug Application For EAL Dated 27 April 2026
Brief: Trading In Shares Of Immunotech Biopharm Will Be Halted At 1:00 PM On April 28, HKEX Says
Brief: Immunotech Biopharm Posts Loss And Total Comprehensive Expense For Year Attributable Rmb230.8 Million
Brief: Immunotech Biopharm Subscribes To Structured Deposit Product With Investment Value Of RMB50 MLN